In a recent study, HyProCure® was scientifically proven to have a less than 6% removal rate and is highly effective in the treatment of partial talotarsal dislocation.
The study was published by The Journal of Foot and Ankle Science.
Extraosseous Talotarsal Stabilization Using HyProCure® in Adults: A 5-year Retrospective Follow-up. Visit http://www.jfas.org/article/S1067-2516(11)00576-X/abstract for the article abstract.
Read the summary here.
Global orthopedic medical device company and leader in foot care solutions. Our products are developed to correct the root problem, not merely treat the symptoms. All products are developed by surgeons with years of experience in their own practices. GraMedica® is the parent company behind HyProCure® and osteo-WEDGE(TM). GraMedica® continues to develop additional product lines to support our mission of “Changing Lives, One Step at a Time.”
No comments:
Post a Comment